Personalized Treatment Strategies for IBD: Improving Patient Care and Outcomes.

Personalizing treatment in inflammatory bowel disease (IBD) requires selecting a medication which is effective in the particular form of disease the patient has. If the initial therapy fails, it is important for clinicians to recognize why the therapy was ineffective and to determine what steps to t...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Managed Care Medicine Vol. 22; no. 2; pp. 5 - 13
Autor principal: Feuerstein, Joseph D.
Formato: tables/charts Journal Article
Publicado: National Association of Managed Care Physicians, Inc. 2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137842433&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 137842433
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10941525
        9084
      jtl: Journal of Managed Care Medicine
      issn: 10941525
      maglogo: N
    pubinfo:
      dt: 2019
      vid: 22
      iid: 2
      pid: 54351
      pub: National Association of Managed Care Physicians, Inc.
      place: Glen Allen, Virginia
    artinfo:
      ui:
        137842433
        137842433
        137842433
        137842433
      ppf: 5
      ppct: 8
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Personalized Treatment Strategies for IBD: Improving Patient Care and Outcomes.
      aug:
        au: Feuerstein, Joseph D.
        affil: Assistant Professor of Medicine at the Harvard Medical School
      sug:
        subj:
          Inflammatory Bowel Diseases Therapy
          Individualized Medicine
          Quality of Health Care
          Quality Improvement
          Outcomes (Health Care)
          Patient Care
          Drug Monitoring
          Consumer Participation
      ab: Personalizing treatment in inflammatory bowel disease (IBD) requires selecting a medication which is effective in the particular form of disease the patient has. If the initial therapy fails, it is important for clinicians to recognize why the therapy was ineffective and to determine what steps to take next. Therapeutic drug monitoring and patient engagement can both be utilized to optimize outcomes.
      pubtype: Academic Journal
      doctype:
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N